Ascendis Pharma A/S (ASND) vs Roivant Sciences Ltd. (ROIV)
Ascendis Pharma A/S and Roivant Sciences Ltd. are both Biotechnology companies. Roivant Sciences Ltd. is the larger, with a market value of $25.6B against $15.7B — 1.6× the size. Roivant Sciences Ltd. has negative trailing earnings, so its P/E is not meaningful; Ascendis Pharma A/S trades at 16.3×. Ascendis Pharma A/S grew revenue faster over the last twelve months: 126.0% against −67.6%. Ascendis Pharma A/S has the higher net margin (71.2% vs −3,535.0%) and the higher return on invested capital (15.1% vs −34.5%). Across the 18 metrics below, Ascendis Pharma A/S leads on 15 and Roivant Sciences Ltd. on 3.
Valuation
Profitability
| Metric | ASND | ROIV | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.26% | 81.21% | 65.16% |
| Operating margin | 24.84% | (7,914.75%) | 0.00% |
| Net margin | 71.20% | (3,534.96%) | 0.00% |
| Free cash flow margin | 31.97% | (10,901.00%) | 0.00% |
| Return on equity | 118.44% | (5.47%) | (57.72%) |
| Return on assets | 44.34% | (5.15%) | (49.22%) |
| Return on invested capital | 15.07% | (34.51%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack